| Literature DB >> 35625243 |
Sofia Santos Costa1, Rute Ribeiro1, Maria Serrano1, Ketlyn Oliveira1, Carolina Ferreira1, Marta Leal1, Constança Pomba2,3, Isabel Couto1.
Abstract
Staphylococcus aureus is a relevant agent of skin and soft tissue infections (SSTIs) in animals. Fifty-five S. aureus comprising all SSTI-related isolates in companion animals, collected between 1999 and 2018 (Lab 1) or 2017 and 2018 (Lab 2), were characterized regarding susceptibility to antibiotics and heavy metals and carriage of antimicrobial resistance determinants. Clonal lineages were established by PFGE, MLST and agr typing. Over half of the isolates (56.4%, 31/55) were methicillin-resistant S. aureus (MRSA), and 14.5% showed a multidrug resistance (MDR) phenotype. Resistance was most frequently observed for beta-lactams (81.8%, related to blaZ and/or mecA), fluoroquinolones (56.4%) and macrolides/lincosamides (14.5%, related to erm(A) or erm(C)). The distributions of heavy-metal MICs allowed the detection of non-wild-type populations associated with several resistance genes. The collection showed genetic diversity, with prevalence of clonal lineage ST22-agrI (45.5%, 25/55), comprising only MRSA isolates, and several less frequently detected clones, including ST5-agrII (14.6%, 8/55), ST398-agrI (9.1%, 5/55) and ST72-agrI (7.3%, 4/55). This work highlights the high frequency of SSTI-related MRSA strains that reflect the clonal lineages circulating both in companion animals and humans in Portugal, reinforcing the need for a One Health approach when studying staphylococci causing infections in companion animals.Entities:
Keywords: MRSA; One Health; Staphylococcus aureus; antimicrobial resistance; clonal lineages; companion animals; heavy metals
Year: 2022 PMID: 35625243 PMCID: PMC9137735 DOI: 10.3390/antibiotics11050599
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Antibiotic susceptibility profiles and resistance genes for the 55 SSTI-related S. aureus isolates studied. Data are only presented for antibiotics with established breakpoints.
| Antibiotic | ZD Breakpoint | Number of Isolates (%) | Resistance Determinants (No. Isolates) | |||
|---|---|---|---|---|---|---|
| S (mm) | R (mm) | S | I | R | ||
| Penicillin ** | ≥29 b | ≤28 b | 10 (18.2%) | - | 45 (81.8%) | |
| Cefoxitin ** | ≥22 | ≤21 | 24 (43.6%) | - | 31 (56.4%) | |
| Enrofloxacin *,a | ≥23 | ≤16 | 24 (43.6%) | 1 (1.8%) | 30 (54.5%) | - |
| Pradofloxacin *,a | ≥24 | ≤19 | 25 (45.5%) | 0 (0%) | 30 (54.5%) | - |
| Ciprofloxacin ** | ≥21 | ≤15 | 24 (43.6%) | 1 (1.8%) | 30 (54.5%) | - |
| Moxifloxacin ** | ≥24 | ≤20 | 25 (45.5%) | 0 (0%) | 30 (54.5%) | - |
| Erythromycin ** | ≥23 | ≤13 | 47 (85.5%) | 0 (0%) | 8 (14.5%) | |
| Clindamycin *,a | ≥21 | ≤14 | 47 (85.5%) | 0 (0%) | 8 (14.5%) c | |
| Quinupristin-dalfopristin ** | ≥19 | ≤15 | 55 (100%) | 0 (0%) | 0 (0%) | - |
| Tetracycline *,a | ≥23 | ≤17 | 53 (96.3%) | 1 (1.8%) | 1 (1.8%) | |
| Minocycline ** | ≥19 | ≤14 | 54 (98.2%) | 1 (1.8%) | 0 (0%) | |
| Tigecycline *** | ≥18 | <18 | 55 (100%) | - | 0 (0%) | - |
| Fusidic acid *** | ≥24 | <24 | 54 (98.2%) | - | 1 (1.8%) | |
| Linezolid ** | ≥21 | ≤20 | 55 (100%) | - | 0 (0%) | - |
| Chloramphenicol ** | ≥18 | ≤12 | 54 (98.2%) | 0 (0%) | 1 (1.8%) | |
| Trimethoprim-sulfamethoxazole ** | ≥16 | ≤10 | 55 (100%) | 0 (0%) | 0 (0%) | - |
| Rifampicin ** | ≥20 | ≤16 | 55 (100%) | 0 (0%) | 0 (0%) | - |
| Gentamicin ** | ≥15 | ≤12 | 53 (96.3%) | 0 (0%) | 2 (3.6%) | |
| Amikacin *** | ≥18 | <15 | 55 (100%) | 0 (0%) | 0 (0%) | - |
| Tobramycin *** | ≥18 | <18 | 53 (96.3%) | - | 2 (3.6%) | |
| Kanamycin *** | ≥18 | <18 | 53 (96.3%) | - | 2 (3.6%) | |
ZD: zone inhibition diameter; S: susceptible; I: intermediate; R: resistant; * Breakpoint established by CLSI for staphylococci isolated from animals, document VET01S ED5 [18]; ** Breakpoint established by CLSI for staphylococci isolated from humans, document M100-S32 [19]; *** Breakpoint established by EUCAST [20]; a The breakpoint used is established for isolates of canine and feline origin (enrofloxacin), only canine origin (clindamycin, tetracycline) or only feline origin (pradofloxacin) [18]; b Isolates with a ZD towards penicillin >29 mm, but with a sharp inhibition border were considered producers of beta-lactamase and thus resistant to penicillin [18]; c All isolates showed inducible resistance to clindamycin; n.i.: not identified.
Figure 1MIC distributions and estimation of cut-off (COWT) values of the 55 SSTI-related S. aureus from companion animals for the heavy metals silver nitrate (AgNO3), zinc chloride (ZnCl2), copper sulphate (CuSO4), cadmium acetate (Cd(CH3COO)2) and disodium hydrogen arsenate (Na2HASO4). The COWT values were estimated with the iterative statistical method using the ECOFFinder datasheet available at https://www.eucast.org/mic_distributions_and_ecoffs/ (accessed on 10 November 2021). The blue columns represent the MIC values determined for all isolates, whereas the green line indicates the distribution of MICs for the wild-type (WT) population estimated by the ECOFFinder. The dashed orange line indicates the COWT value that corresponds to the highest MIC value of the estimated WT population.
Cut-off (COWT) values of S. aureus for the five heavy metals. The COWT values and estimated wild-type (WT) and non-wild-type (NWT) populations were determined based on the MIC distributions using ECOFFinder.
| COWT | SD | WT Population | NWT Population | |||
|---|---|---|---|---|---|---|
| X ≤ COWT | No. Isolates (%) | X > COWT | No. Isolates (%) | |||
| Silver nitrate (AgNO3) | 0.125 mM | 0.48 | ≤0.125 mM | 55 (100%) | >0.125 mM | 0 (0%) |
| Zinc chloride (ZnCl2) | 8 mM | 0.79 | ≤8 mM | 55 (100%) | >8 mM | 0 (0%) |
| Copper sulphate (CuSO4) | --- | --- | --- | --- | --- | --- |
| Cadmium acetate (Cd(CH3COO)2) | 16 mM * | 3.20 * | --- | --- | --- | --- |
| Disodium hydrogen arsenate (Na2HAsO4) | 4 mM | 0.74 | ≤4 mM | 45 (72.7%) | >4 mM | 10 (18.2%) |
SD: standard deviation; WT: wild-type; NWT: non-wild-type. * Cut-off values associated with a high SD (>1 log2) were not considered accurate.
Figure 2SmaI-PFGE profiles of the S. aureus isolates associated with SSTIs in companion animals and corresponding clonal lineages as determined by MLST and their correlation with host, agr types, phenotypic and genotypic resistance traits. The pairs of isolates recovered from the same animal are marked by (A) to (D), where each letter corresponds to a different animal. The dendrogram was built using Bionumerics and the UPGMA algorithm, using the Dice coefficient, an optimization of 0.5% and a tolerance of band of 1%. The dashed lines correspond to the similarity criteria for considering isolates belonging to the same PFGE type (≥80%) or subtype (≥97%). Isolates sharing the same PFGE type or subtype were considered as belonging to the same sequence type (ST). The isolates subjected to MLST are indicated in bold type. Unk: unknown host; CC: clonal complex; ST: sequence type; PFGE: pulsed-field gel electrophoresis; PEN: penicillin; CXI: cefoxitin; ERY: erythromycin; CLI: clindamycin; CIP: ciprofloxacin; ENR: enrofloxacin; MOX: moxifloxacin; PRA: pradofloxacin; KAN: kanamycin; GEN: gentamycin; TOB: tobramycin; FUS: fusidic acid; BCT: bacitracin.
Figure 3Relationship between clonal lineages, host and methicillin resistance among the 55 SSTI-related S. aureus isolates. The relationship between clonal lineages was estimated using the goeBurst algorithm available at PhyloViz Online. Clonal lineages sharing at least four alleles are linked with solid lines; numbers correspond to the diverging alleles.